February 27, 2025 10:09 AM EST
News Briefing

Han­soh ends col­lab­o­ra­tion with Si­lence; Vir hunts for HBV drug part­ner

ENDPOINTS

Plus, news about Alopexx, Medi­gene, EpimAb and Be­lite Bio:

Han­soh backs out of siR­NA pact with Si­lence Ther­a­peu­tics: The Lon­don-based biotech

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

TIG­IT grave­yard ex­pands as GSK drops late-stage as­set with iTeos

Unit­ed­Health Group CEO An­drew Wit­ty steps down

CRISPR patent spat re­vived by fed­er­al ap­peals court rul­ing

Bay­er starts 2025 by cut­ting 2,000 jobs as it homes in on year-end re­haul tar­get

HHS fo­cus­es on 'trans­paren­cy' in third-round IRA ne­go­ti­a­tion guid­ance

Arc­turus to pri­or­i­tize mR­NA ther­a­peu­tics in bid to boost rare dis­ease pro­grams

A service from the Financial Times